134 related articles for article (PubMed ID: 31153515)
1. The evaluation of anti-tuberculosis drug effects on phenotypes of Mycobacterium tuberculosis not detected by culture methods.
Kayigire XA; Friedrich SO; van der Merwe L; Diacon AH
Tuberculosis (Edinb); 2019 May; 116():32-34. PubMed ID: 31153515
[No Abstract] [Full Text] [Related]
2. Initial screening of extra-pulmonary tuberculosis using the Xpert MTB/RIF assay improves case detection rates.
Jain A; Singh PK; Singh U; Kumar V
Int J Tuberc Lung Dis; 2017 Apr; 21(4):478-480. PubMed ID: 28284274
[No Abstract] [Full Text] [Related]
3. [Rapid prediction of rifampin susceptibility of Mycobacterium tuberculosis].
Rinder H
Pneumologie; 1998 Feb; 52(2):91-2. PubMed ID: 9557056
[No Abstract] [Full Text] [Related]
4. Fluorescein diacetate vital staining allows earlier diagnosis of rifampicin-resistant tuberculosis.
Van Deun A; Maug AK; Hossain A; Gumusboga M; de Jong BC
Int J Tuberc Lung Dis; 2012 Sep; 16(9):1174-9. PubMed ID: 22747903
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a commercial probe assay for detection of rifampin resistance in Mycobacterium tuberculosis directly from respiratory and nonrespiratory clinical samples.
Gamboa F; Cardona PJ; Manterola JM; Lonca J; Matas L; Padilla E; Manzano JR; Ausina V
Eur J Clin Microbiol Infect Dis; 1998 Mar; 17(3):189-92. PubMed ID: 9665301
[TBL] [Abstract][Full Text] [Related]
6. Xpert MTB/RIF false detection of rifampin-resistant tuberculosis from prior infection.
Kelly JD; Grace Lin SY; Barry PM; Keh C; Higashi J; Metcalfe JZ
Am J Respir Crit Care Med; 2014 Dec; 190(11):1316-8. PubMed ID: 25436783
[No Abstract] [Full Text] [Related]
7. Diagnostic dilemma: treatment outcomes of tuberculosis patients with inconsistent rifampicin susceptibility.
Pang Y; Ruan YZ; Zhao J; Chen C; Xu CH; Su W; Huan ST; Li RZ; Zhao YL; Chin DP; Wang LX
Int J Tuberc Lung Dis; 2014 Mar; 18(3):357-62. PubMed ID: 24670576
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic yield of Bronchoalveolar Lavage gene Xpert in smear-negative and sputum-scarce pulmonary tuberculosis.
Khalil KF; Butt T
J Coll Physicians Surg Pak; 2015 Feb; 25(2):115-8. PubMed ID: 25703755
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous staining of sputum smears for acid-fast and lipid-containing Myobacterium tuberculosis can enhance the clinical evaluation of antituberculosis treatments.
Kayigire XA; Friedrich SO; van der Merwe L; Donald PR; Diacon AH
Tuberculosis (Edinb); 2015 Dec; 95(6):770-779. PubMed ID: 26318558
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of GeneXpert MTB/RIF Assay for Detection of Pulmonary Tuberculosis on Sputum Samples.
Yasemin A; Ahmad S; Afzal S; Ullah A; Sheed A
J Coll Physicians Surg Pak; 2019 Jan; 29(1):66-69. PubMed ID: 30630573
[TBL] [Abstract][Full Text] [Related]
11. Modern methods for assessing the drugs used in the chemotherapy of mycobacterial disease.
Mitchison DA
Soc Appl Bacteriol Symp Ser; 1996; 25():72S-80S. PubMed ID: 8972122
[No Abstract] [Full Text] [Related]
12. [Drug resistance of Mycobacteria tuberculosis in patients with new-onset pulmonary tuberculosis].
Khudushina TA; Voloshina EP; Adamovich NV; Maslakova MG; Terekhova ND
Probl Tuberk Bolezn Legk; 2005; (12):37-9. PubMed ID: 16496762
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis of tuberculosis].
Rüsch-Gerdes S
Internist (Berl); 1995 Oct; 36(10):957-60. PubMed ID: 7499071
[No Abstract] [Full Text] [Related]
14. Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings.
Luetkemeyer AF; Firnhaber C; Kendall MA; Wu X; Mazurek GH; Benator DA; Arduino R; Fernandez M; Guy E; Johnson P; Metchock B; Sattler F; Telzak E; Wang YF; Weiner M; Swindells S; Sanne IM; Havlir DV; Grinsztejn B; Alland D;
Clin Infect Dis; 2016 May; 62(9):1081-8. PubMed ID: 26839383
[TBL] [Abstract][Full Text] [Related]
15. Liquid mycobacterial culture outcomes after different sputum collection techniques before and during treatment.
Lourens M; Philips L; Kleinhans CC; Friedrich SO; Martinson N; Venter A; van der Merwe L; Diacon AH
Tuberculosis (Edinb); 2019 May; 116():17-21. PubMed ID: 31153513
[TBL] [Abstract][Full Text] [Related]
16. Time to positivity in liquid culture predicts colony forming unit counts of Mycobacterium tuberculosis in sputum specimens.
Diacon AH; van der Merwe L; Demers AM; von Groote-Bidlingmaier F; Venter A; Donald PR
Tuberculosis (Edinb); 2014 Mar; 94(2):148-51. PubMed ID: 24456754
[TBL] [Abstract][Full Text] [Related]
17. Selective malabsorption and the origin of mono-rifampin-resistant Mycobacterium tuberculosis.
Perlman DC; Salomon N
Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1213. PubMed ID: 8887622
[No Abstract] [Full Text] [Related]
18. Predictors of cure in rifampicin-resistant tuberculosis in prison settings with low loss to follow-up.
Gurbanova E; Mehdiyev R; Blondal K; Altraja A
Int J Tuberc Lung Dis; 2016 May; 20(5):645-51. PubMed ID: 27084819
[TBL] [Abstract][Full Text] [Related]
19. False-positive Xpert(®) MTB/RIF assays and previous treatment.
Boyles TH; Hughes J; Cox V; Burton R; Meintjes G; Mendelson M
Int J Tuberc Lung Dis; 2015 Apr; 19(4):495-6. PubMed ID: 25860011
[No Abstract] [Full Text] [Related]
20. Evaluation of Xpert MTB/RIF assay for detection of Mycobacterium tuberculosis in stool samples of adults with pulmonary tuberculosis.
Rahman SMM; Maliha UT; Ahmed S; Kabir S; Khatun R; Shah JA; Banu S
PLoS One; 2018; 13(9):e0203063. PubMed ID: 30212505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
